[HTML][HTML] Advances in the management of primary membranous nephropathy and rituximab-refractory membranous nephropathy
M Teisseyre, M Cremoni, S Boyer-Suavet… - Frontiers in …, 2022 - frontiersin.org
Primary membranous nephropathy (pMN) is an auto-immune disease characterized by auto-
antibodies targeting podocyte antigens resulting in activation of complement and damage to …
antibodies targeting podocyte antigens resulting in activation of complement and damage to …
[HTML][HTML] Membranous nephropathy: systems biology-based novel mechanism and traditional Chinese medicine therapy
H Miao, Y Zhang, X Yu, L Zou, Y Zhao - Frontiers in Pharmacology, 2022 - frontiersin.org
Membranous nephropathy (MN) is a renal-limited non-inflammatory autoimmune disease in
the glomerulus, which is the second or third main cause of end-stage kidney diseases in …
the glomerulus, which is the second or third main cause of end-stage kidney diseases in …
[HTML][HTML] Recent advances in clinical diagnosis and pharmacotherapy options of membranous nephropathy
YN Wang, HY Feng, X Nie, YM Zhang, L Zou… - Frontiers in …, 2022 - frontiersin.org
Membranous nephropathy (MN) is the most common cause of nephrotic syndrome among
adults, which is the leading glomerular disease that recurs after kidney transplantation …
adults, which is the leading glomerular disease that recurs after kidney transplantation …
[HTML][HTML] Rituximab therapy for adults with nephrotic syndromes: standard schedules or B cell-targeted therapy?
L Del Vecchio, M Allinovi, P Rocco… - Journal of Clinical …, 2021 - mdpi.com
Rituximab is a chimeric anti-CD20 monoclonal antibody. It acts mainly through complement-
dependent cytotoxicity on B cells expressing the CD20 marker. In this review, we analyse …
dependent cytotoxicity on B cells expressing the CD20 marker. In this review, we analyse …
Changes and significance of Treg and Th17 in adult patients with primary membranous nephropathy
M Dong-hong, Y Xiao-dong, H Qiu-ju… - Clinical …, 2021 - search.proquest.com
Objective: To investigate the changes in Treg and Th17 cells and explore the significance of
Treg/Th17 balance in adult primary membranous nephropathy (PMN) patients. Materials …
Treg/Th17 balance in adult primary membranous nephropathy (PMN) patients. Materials …
[HTML][HTML] 膜性肾病生物标志物的研究进展
唐钰书， 谢席胜 - Advances in Clinical Medicine, 2023 - hanspub.org
特发性膜性肾病(idiopathic membranous nephropathy, IMN) 是一种常见的免疫性肾脏疾病,
是成人终末期肾病的重要病因之一. 及时诊断, 规范治疗和定期随访关乎患者预后. 关于M …
是成人终末期肾病的重要病因之一. 及时诊断, 规范治疗和定期随访关乎患者预后. 关于M …
[HTML][HTML] M 型磷脂酶A2 受体在特发性膜性肾病中的临床应用
唐钰书， 谢席胜 - Advances in Clinical Medicine, 2023 - hanspub.org
特发性膜性肾病(Idiopathic membranous nephropathy, IMN) 是一种常见的免疫性肾脏疾病,
起病隐匿, 临床表现复杂, 并发症多, 预后较差. 经研究, M 型磷脂酶A 2 受体被证实为成人IMN …
起病隐匿, 临床表现复杂, 并发症多, 预后较差. 经研究, M 型磷脂酶A 2 受体被证实为成人IMN …
Glomérulonéphrite extramembraneuse: outils diagnostiques, pronostiques et d'aide à la décision thérapeutique
M Cremoni, M Teisseyre, B Seitz-Polski - Revue Francophone des …, 2024 - Elsevier
Résumé La glomérulonéphrite extramembraneuse est une maladie auto-immune rénale
rare principalement causée par des auto-anticorps dirigés contre des antigènes …
rare principalement causée par des auto-anticorps dirigés contre des antigènes …